Salivary and serum nitric oxide synthase, macrophage inflammatory protein 1 alpha and macrophage migration inhibitory factor levels in periodontal disease

被引:0
|
作者
Oner, Fatma [1 ]
Onat, Faruk Cagri [2 ]
Karasu, Yerda Ozkan [2 ,3 ]
机构
[1] Bahcesehir Univ, Fac Dent Med, Dept Periodontol, Istanbul, Turkiye
[2] Ataturk Univ, Fac Dent & Med, Dept Periodontol, Erzurum, Turkiye
[3] Ataturk Univ, Fac Dent Med, Dept Periodontol, TR-25200 Yakutiye Erzurum, Turkiye
关键词
Gingivitis; iNOS; MIP-1; alpha; MIF; Periodontitis; PERI-IMPLANT DISEASES; 2017 WORLD WORKSHOP; CONSENSUS REPORT; MIP-1-ALPHA; EXPRESSION; BIOMARKERS; MIF; CLASSIFICATION; CONTRIBUTES; IMMUNITY;
D O I
10.1016/j.heliyon.2024.e25888
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Periodontal disease is multifactorial inflammatory disease involving both gingivitis and periodontitis. Inducible nitric oxide synthase (iNOS), macrophage inflammatory protein 1 alpha (MIP-1 alpha) and macrophage migration inhibitory factor (MIF) are mediators contributing to the progression of periodontal diseases with distinct functions. The aim of this study is to evaluate the local and systemic iNOS, MIP-1 alpha and MIF concentrations in patients having periodontal disease with different severities. Design: The study was conducted on 88 individuals equally divided into four groups; 1) Periodontally Healthy 2) Gingivitis 3) Stage I-II Periodontitis 4) Stage III-IV Periodontitis. Saliva and serum samples were obtained from each individual and then periodontal examinations were performed. Plaque and bleeding on probing indexes, probing depths and clinical attachment levels were measured on each tooth to determine the periodontal status. Concentrations of iNOS, MIP-1 alpha and MIF were measured with enzyme -linked immunosorbent assay. Results: Patients with stage I-II and stage III-IV periodontitis had more iNOS levels than periodontally healthy people in serum and saliva (p <= 0,001 for serum; p < 0,05 for saliva). Stage III-IV periodontitis group had significantly more serum-iNOS levels than that in gingivitis group (p = 0,005). When compared with periodontally healthy individuals, MIP-1 alpha levels in stage III-IV periodontitis patients were measured significantly more in saliva; (p = 0,016) but less in serum (p = 0,006) samples. More serum-MIF concentrations were observed in stage I-II periodontitis groups than that in periodontally healthy individuals (p < 0,05). Conclusion: Increased salivary and serum iNOS and serum-MIF levels in different stages of periodontitis suggest that these molecules might be involved in periodontal disease pathogenesis. Also, oral microenvironment may stimulate the enhanced MIP-1 alpha concentration in advanced periodontitis cases.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients
    Chen, LC
    Lei, HY
    Liu, CC
    Shiesh, SC
    Chen, SH
    Liu, HS
    Lin, YS
    Wang, ST
    Shyu, HW
    Yeh, TM
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 74 (01): : 142 - 147
  • [22] Elevated serum levels of macrophage migration inhibitory factor (MIF) in patients with Behcet's disease.
    Kim, SD
    Kim, SH
    Kim, HR
    Park, MK
    Yoon, CH
    Kim, WU
    Lee, SH
    Kang, I
    Cho, CS
    Kim, HY
    Park, SH
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S232 - S232
  • [23] Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease
    Oliver, J.
    Marquez, A.
    Gomez-Garcia, M.
    Martinez, A.
    Mendoza, J. L.
    Vilchez, J. R.
    Lopez-Nevot, M. A.
    Pinero, A.
    de la Concha, E. G.
    Nieto, A.
    Urcelay, E.
    Martin, J.
    GUT, 2007, 56 (01) : 150 - 151
  • [24] Overview of the Role of Macrophage Migration Inhibitory Factor (MIF) in Inflammatory Bowel Disease
    Nishihira, Jun
    Mitsuyama, Keiichi
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (18) : 2104 - 2109
  • [25] Marked elevation of serum macrophage migration inhibitory factor levels in patients with pemphigus vulgaris
    Namazi, Mohammad Reza
    Fallahzadeh, Mohammad Kazem
    Shaghelani, Hassan
    Kamali-Sarvestani, Eskandar
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (02) : 146 - 148
  • [26] Increased serum levels and epithelial expression of macrophage migration inhibitory factor in gastric cancer
    He, XX
    Xia, HHX
    Yang, Y
    Lam, SK
    Lin, MCM
    Wong, WM
    Kung, HF
    Leung, SY
    Yuen, ST
    Zhao, YH
    Wong, BCY
    GASTROENTEROLOGY, 2003, 124 (04) : A556 - A556
  • [27] Elevated levels of serum macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis
    Matsunawa, Mizuho
    Kanemitsu, Hirohito
    Wakabayashi, Kuninobu
    Odai, Tsuyoshi
    Isozaki, Takeo
    Yajima, Nobuyuki
    Miwa, Yusuke
    Kasama, Tsuyoshi
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S851 - S851
  • [28] Macrophage migration inhibitory factor (MIF) serum levels are elevated in patients with severe sepsis
    Lehmann, LE
    Schroeder, S
    Hoeft, A
    Stüber, F
    CRITICAL CARE MEDICINE, 1999, 27 (01) : A86 - A86
  • [29] Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum
    Bansal, Frainey
    Narang, Tarun
    Dogra, Sunil
    Vinay, Keshavamurthy
    Chhabra, Seema
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2018, 84 (05): : 573 - 577
  • [30] Elevated Serum Macrophage Migration Inhibitory Factor Levels are Associated With Major Depressive Disorder
    Supti, Kaniz Farzana
    Asaduzzaman, Md.
    Suhee, Farhana Islam
    Shahriar, Mohammad
    Islam, Sardar Mohammad Ashraful
    Bhuiyan, Mohiuddin Ahmed
    Qusar, M. M. A. Shalahuddin
    Islam, Md. Rabiul
    CLINICAL PATHOLOGY, 2023, 16